Cargando…
Redirecting an Anticancer to an Antibacterial Hit Against Methicillin-Resistant Staphylococcus aureus
YM155 is a clinically evaluated anticancer with a fused naphthoquinone-imidazolium scaffold. In this study, we demonstrated that based on weak or cryptic antibacterial activity of YM155 against methicillin-resistant Staphylococcus aureus (MRSA) (MIC of 50 μg/ml), some congeneric compounds with short...
Autores principales: | Jang, Hye-Jeong, Chung, In-Young, Lim, Changjin, Chung, Sungkyun, Kim, Bi-o, Kim, Eun Sook, Kim, Seok-Ho, Cho, You-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398426/ https://www.ncbi.nlm.nih.gov/pubmed/30858845 http://dx.doi.org/10.3389/fmicb.2019.00350 |
Ejemplares similares
-
Antibacterial Activity of Rhus javanica against Methicillin-Resistant Staphylococcus aureus
por: You, Yong-Ouk, et al.
Publicado: (2013) -
Rapid Discrimination of Methicillin-Resistant Staphylococcus aureus by MALDI-TOF MS
por: Kim, Jung-Min, et al.
Publicado: (2019) -
Susceptibility of Methicillin-Resistant Staphylococcus aureus to Five Quinazolinone Antibacterials
por: Ceballos, Sara, et al.
Publicado: (2019) -
Preparation and characterization of spiked gold nanobipyramids and its antibacterial effect on methicillin-resistant Staphylococcus aureus and methicillin-sensitive Staphylococcus aureus
por: Huynh, Phat Trong, et al.
Publicado: (2023) -
2129. When Is Methicillin-resistant Staphylococcus aureus not Methicillin-resistant Staphylococcus aureus?
por: Gitman, Melissa R, et al.
Publicado: (2019)